Sugar Maple Asset Management »

Aquestive Therapeutics shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $67k 12k 5.59
2025-06-30 $40k 12k 3.31
2025-03-31 $86k 30k 2.90

More positions owned by Sugar Maple Asset Management

Abbvie (ABBV)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Core S&p500 Etf (IVV)
Abbott Laboratories (ABT)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Silver Tr Ishares (SLV)
Vaneck Etf Trust Clo Etf (CLOI)
T Rowe Price Etf Cap Appreciation (TCAF)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Specialized Funds Div App Etf (VIG)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Spdr Series Trust S&p Divid Etf (SDY)

View all positions for Sugar Maple Asset Management

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
Geode Capital Management
State Street Corporation
Sio Capital Management
Susquehanna International
Morgan Stanley
Millennium Management
Blue Owl Capital Holdings
Janney Montgomery Scott

View all funds holding Aquestive Therapeutics